ArticleEuropean urology2022
Robot-assisted Radical Prostatectomy with the Novel Hugo Robotic System: Initial Experience and Optimal Surgical Set-up at a Tertiary Referral Robotic Center.
Article in European urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
69 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Perioperative efficacy and safety of the MP1000 robotic surgical system versus the da Vinci robotic surgical system in urologic surgery: a systematic review and meta-analysis.Journal of robotic surgery · 2026Pooled it
- Perioperative, functional, and oncological outcomes of Da Vinci vs. Hugo RAS for robot‑assisted radical prostatectomy: evidence based on controlled studies.Journal of robotic surgery · 2024Pooled it
- A comprehensive evaluation and meta-analysis of the perioperative and oncological outcomes of robotic radical prostatectomy using the DaVinci vs the Hugo RAS surgical platforms.Journal of robotic surgery · 2024Pooled it
- Emerging multi-port soft tissue robotic systems: a systematic review of clinical outcomes.Journal of robotic surgery · 2024Pooled it
- Robot-assisted partial nephrectomy and robot-assisted radical prostatectomy using the Chinese surgical systems KangDuo-SR-2000 and EDGE MP1000 versus the Da Vinci Xi system: a prospective, single-center, non-randomized clinical trial.World journal of urology · 2025Trial
- Early matched comparison of a novel modular carina robotic platform and the da vinci system for robot-assisted radical prostatectomy.Journal of robotic surgery · 2026Article
- Emerging robotic platforms in urologic surgery: a bibliometric and visualization analysis of global trends and research hotspots.Journal of robotic surgery · 2026Review
- Grid carbon intensity drives the electricity-related carbon footprint of robot-assisted radical prostatectomy: a cross-jurisdiction modelling study.Scientific reports · 2026Article
- Surgical Technique and Perioperative and Postoperative Outcomes for Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion Performed with the Hugo RAS Robotic Platform: First Large Case Series by the European Association of Urology Robotic Urology Section Scientific Working Group.European urology open science · 2026Article
- Comprehensive Comparison of Features of Robotic Surgery Systems in Abdominal Surgeries: A Narrative Review Study.Health science reports · 2026Article
- Robot-assisted sacrocolpopexy using the Hugo-RAS system: initial series with no experience in robotic surgery.Gynecology and pelvic medicine · 2026Article
- Robot-assisted anatomical lung resection with a modular robotic system: Preliminary experience from a single-arm, prospective trial.JTCVS techniques · 2025Article
- Beyond Da Vinci: Comparative Review of Next-Generation Robotic Platforms in Urologic Surgery.Journal of clinical medicine · 2025Review
- Article
- Impact of prior robotic surgical expertise on the results of Hugo RAS radical prostatectomy: a propensity score-matched comparison between Da Vinci-expert and non-Da Vinci-expert surgeons.World journal of urology · 2025Article
- Robotic urologic applications of the hinotori™ Surgical Robot System.Asian journal of urology · 2025Article
- Perioperative, Oncological, and Functional Outcomes of New Multiport Robotic Platforms in Urology: A Systematic Review and Meta-analysis.European urology open science · 2025Review
- New surgical robotic platforms in China and their applications in urologic surgeries.Asian journal of urology · 2025Article
- Comparison of perioperative outcomes of robot-assisted radical prostatectomy among the da Vinci, hinotori, and Hugo robot-assisted surgery systems.Journal of robotic surgery · 2025Article
- Early clinical evaluation of the Hugo robotic-assisted surgery (RAS) for performing radical prostatectomy: an IDEAL stage 2 study.BMJ surgery, interventions, & health technologies · 2025Article
9 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We describe the first five robot-assisted radical prostatectomies (RARPs) performed with the new Hugo RAS system (Medtronic, Minneapolis, MN, USA) in Europe. The five patients underwent RARP ± lymph node dissection at OLV Hospital (Aalst, Belgium). All procedures were completed, with no need for conversion or for placement of additional ports. No intraoperative complication or technical failure of the system was recorded. The median operative time was 170 min (interquartile range [IQR]: 140-180) and the median console time was 120 min (IQR: 110-150). Median length of stay was 3 d (IQR: 2-4). System start-up and docking of the robotic arms were straightforward and rapid processes for a properly trained surgical team. Awaiting future investigations in larger series, this study proves the safety and feasibility of RARP with the Hugo RAS system and provides relevant data that may be of help to early adopters of this surgical platform.
Indexed as
Identifiers
35568597What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.